Callio Therapeutics develops multi-payload antibody-drug conjugates for cancer therapy.

Sunbird Bio develops a blood-based diagnostic platform for early and accurate detection of neurological disorders like Alzheimer’s and Parkinson’s disease.

Engine Biosciences uses machine learning and high-throughput biology to develop precision oncology medicines, and with their recent funding, they plan to advance their biomarker and target discoveries toward the clinic through internal development, collaborations, and partnerships.

Automera is a biotechnology company that develops autophagy-targeting chimera small molecules (AUTACs) for the treatment of cancer and other diseases, using quantum chemistry and AI-enabled drug discovery tools to generate novel therapeutic leads.